G364-0137 Screening compound: N~1~-(3-fluorophenyl)-2-[6-(3-methylbenzyl)-1,1-dioxo-1lambda~6~,2,6-thiadiazinan-2-yl]acetamide

G364-0137 Screening compound: N~1~-(3-fluorophenyl)-2-[6-(3-methylbenzyl)-1,1-dioxo-1lambda~6~,2,6-thiadiazinan-2-yl]acetamide
G364-0137 Screening compound: N~1~-(3-fluorophenyl)-2-[6-(3-methylbenzyl)-1,1-dioxo-1lambda~6~,2,6-thiadiazinan-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G364-0137
N~1~-(3-fluorophenyl)-2-[6-(3-methylbenzyl)-1,1-dioxo-1lambda~6~,2,6-thiadiazinan-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G364-0137

Molecular Formula

C19H22FN3O3S (C19 H22 FN3 O3 S)

Compound Name

N~1~-(3-fluorophenyl)-2-[6-(3-methylbenzyl)-1,1-dioxo-1lambda~6~,2,6-thiadiazinan-2-yl]acetamide

IUPAC name

N-(3-fluorophenyl)-2-{6-[(3-methylphenyl)methyl]-11-dioxo-1lambda626-thiadiazinan-2-yl}acetamide

SMILES

Cc1cccc(CN(CCCN2CC(Nc3cc(F)ccc3)=O)S2(=O)=O)c1

InChI

InChI=1S/C19H22FN3O3S/c1-15-5-2-6-16(11-15)13-22-9-4-10-23(27(22,25)26)14-19(24)21-18-8-3-7-17(20)12-18/h2-3,5-8,11-12H,4,9-10,13-14H2,1H3,(H,21,24)

InChI Key

LHWPFYHJOODJNR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15003475

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

391.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.239

Distribution Coefficient, logD

3.239

Water Solubility, LogSw

-3.37

Polar Surface Area

59.528

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

-0.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

G364-0137 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G364-0137 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G364-0137?
Check Price and Availability of G364-0137, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G364-0137 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G364-0137
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G364-0137
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G364-0137 available by request